{"database": "lobbying", "table": "lobbying_activities", "rows": [[2343466, "5c11de4f-4c88-4fe0-ac8e-c39e8d96389c", "Q3", "MARSHALL & POPP, LLC", 401105121, "SANOFI U.S. SERVICES, INC.", 2019, "third_quarter", "PHA", "Issues related to prescription drug value - S.2543: Prescription Drug Pricing Reduction Act of 2019; H.R.3: Lower Drug Costs Now Act of 2019.\n\nBiosimilars.\n\nImportation of prescription drugs.\n\n340B issues.\n\nFDA regulatory issues, including the International Pricing Index and Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),White House Office", 40000, null, 0, 0, "2019-10-16T09:19:31.713000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2343466"], "units": {}, "query_ms": 31.108033028431237, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}